Extrapyramidal symptoms and oestrogen

Acta Psychiatrica Scandinavica

Volumn 101, Issue 2, 2000, Pages 130-134

  Thompson, K N ^a,c   Kulkarni, J ^a   Sergejew, A A ^b  

^a MONASH UNIVERSITY   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c PACE Clinic   (Australia)

Author keywords

Menstrual cycle; Neuroleptics; Oestrogen; Schizophrenia; Side effects; Women

Indexed keywords

CLOZAPINE; ESTROGEN; ESTROGEN RECEPTOR; NEUROLEPTIC AGENT; PROGESTERONE; RISPERIDONE;

ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG CROSS REACTIVITY; ESTROGEN BLOOD LEVEL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HYPERKINESIA; MENSTRUAL CYCLE; MESOLIMBIC DOPAMINERGIC SYSTEM; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; STRIATE CORTEX;

ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CROSS-OVER STUDIES; DRUG SYNERGISM; ESTROGENS; FEMALE; HUMANS; MENSTRUAL CYCLE; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 0033974318     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2000.90067.x     Document Type: Article

References (16)

1. 1. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990;16: 185-194.
2. 2. Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20:203-213.
3. 3. Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993;33:207-209.
4. 4. Sherwin BB. Estrogen and cognitive functioning in women. Soc Exp Biol Med 1998;217:17-22.
5. 5. Maggi A, Perez J. Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci 1985;37: 893-906.
6. 6. McEwen BS. Actions of sex hormones on the brain: 'organisation' and 'activation' in relation to functional teratology. Progr Brain Res 1988;73:121-134.
7. 7. MacLusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science 1981;211:1294-1303.
8. 8. Hafner H, Riecher-Rossler A, An der Heiden W, Maurer K, Fatkenheuer B, Loffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993;23:925-940.
9. 9. Di Paolo T, Poyet P, Labrie F. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 1981;73:105-106.
10. 10. Bedard PJ, Boucher R. Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys. Neurosci Lett 1986;64:206-210.
11. 11. Seeman MV. Interaction of sex, age, and neuroleptic dose. Compr Psychiatry 1983;24:125-128.
12. 12. Session DR, Pearlstone R, Jewelewicz R, Kelly AC. Oestrogens and Parkinson's disease. Med Hypotheses 1994; 42:280-282.
13. 13. Villeneuve A, Cazejust T, Cote M. Oestrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 1980;6:145-151.
14. 14. Chouinard G, Ross-Chouinard A, Annable L, Jones BD. Extrapyramidal symptom rating scale. J Neurol Sci 1980;7:233.
15. 15. Karniski W, Blair RC, Snider AD. An exact statistical method for comparing topographic maps, with any number of subjects and electrodes. Brain Topogr 1994;6:203-210.
16. 16. Van Hartesveldt C, Joyce JN. Effects of estrogen on the basal ganglia. Neurosci Biobehav Rev 1986;10:1-14.